ArticleACS measurement science au2026
Quantitative MALDI-MSI Workflow for Lipids with a LC-MS-Based Quality Control Pipeline.
Article in ACS measurement science au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MALDI Mass Spectrometry Imaging in Alzheimer's Disease Lipidomics: Matrix Selection, Spatial Lipid Pathology and Emerging Analytical Strategies.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mass spectrometry imaging (MSI) has established itself as a major analytical method in the spatial analysis of biological tissue. Besides qualitative mapping of analyte distributions, recent developments aim to achieve quantification of target analytes. After successful spatial quantification of pharmaceuticals, the field is now shifting toward endogenous biomolecules such as lipids and metabolites. Here, we present a quantitative MSI (qMSI) workflow for endogenous lipids employing matrix-assisted laser desorption/ionization (MALDI) and stable isotope labeled standards (SILS) integrated into a quality control pipeline utilizing quantitative reversed-phase liquid chromatography tandem mass spectrometry (RP-LC-MS/MS). We thoroughly characterized the standard deposition of 13 lipid SILS with a focus on homogeneity and detection errors on mouse heart septa with intraday coefficient of variations (CVs) of ≤15%. Unlike RP-LC-MS/MS for which CV values increase mainly for lowly abundant lipids, variations of lipids in MALDI-MSI are affected by concentration as well as lipid class. Additionally, we compared lipid annotations based on MALDI-MSI and RP-LC-MS/MS and correlated these annotations between the methods based on quantification results. This method comparison revealed that most polar lipids such as PCs or SMs are captured in both MALDI-MSI and RP-LC-MS/MS, whereas less polar compounds such as TGs exhibit limited overlap. These results highlight that a determination of the SILS amounts and lipid annotations via RP-LC-MS/MS is necessary to counter the increase variability during quantitative MALDI-MSI. To demonstrate the analytical capabilities of the quantitative MALDI-MSI pipeline combined with RP-LC-MS/MS quality control steps, we analyzed mouse kidney from a two-hit heart failure with preserved ejection fraction model and achieved good comparability between RP-LC-MS/MS and MALDI-MSI quantitation results. Our data suggest increased ether lipid concentrations in obese mice kidney, likely to cope with increased oxidative stress induced by the progressing disease state of the mice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.